St. Anna Children's Cancer Research Institute (CCRI)
Barbara Hofschneider has a diverse and extensive work experience. Barbara is currently serving as the Head of Marketing, Communication & Fundraising at St. Anna Kinderkrebsforschung (Children's Cancer Research Institute - CCRI) since January 2023. Before that, since September 2018, they have been the owner and consultant at DIE HOF, specializing in Communication Consulting & Brand Strategy.
From April 2017 to September 2018, Barbara was the Head of Operations & Marketing at mything GmbH. Prior to that, they held the position of Brand Manager (Marketing & Communications) at bwin.party digital entertainment from August 2012 to April 2017.
Barbara's earlier experience includes working as Etat Director at Young & Rubicam from 2011 to 2012, at EURO RSCG from 2007 to 2011, and at Draftfcb from 2000 to 2007.
Barbara Hofschneider attended Werbe Akademie Wien from 1998 to 2000, where they obtained a Diplom in Werbung & Kommunikation.
This person is not in any offices
St. Anna Children's Cancer Research Institute (CCRI)
The St. Anna Children's Cancer Research Institute (St Anna CCRI), located in the center of Vienna, the world's most livable city and one of Europe's most important places for biomedical research and life sciences, is an internationally renowned multidisciplinary research institution with the aim to develop and optimize diagnostic, prognostic, and therapeutic strategies for the treatment of children and adolescents with cancer. To achieve this goal we combine basic research with translational and clinical research and focus on the specific characteristics of childhood tumor diseases in order to provide young patients with the best possible and most innovative therapies. Dedicated research groups in the fields of tumor genomics and epigenomics, immunology, molecular biology, cell biology, bioinformatics and clinical research are working together to harmonize scientific findings with the clinical needs of physicians to ultimately improve the wellbeing of our patients. Through close cooperation between clinic and research, the CCRI provides an ideal environment for cutting-edge research and its translation into clinical practice. To achieve our ultimate goal of advancing the well-being of patients, the CCRI constantly pushes scientific boundaries and strongly promotes close collaboration and exchange with external institutions like the Medical University of Vienna, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) and the Institute of Molecular Pathology (IMP).